Samuel Filipe Cardoso de Paula, Isac George Rosset & André Luiz Meleiro Porto. (2021) Hydroxylated steroids in C-7 and C-15 positions from progesterone bio-oxidation by the marine-derived fungus Penicillium oxalicum CBMAI 1996. Biocatalysis and Agricultural Biotechnology 37, pages 102167.
Crossref
Charleen G. Don & Martin Smieško. (2018) Out‐compute drug side effects: Focus on cytochrome P450 2D6 modeling. WIREs Computational Molecular Science 8:5.
Crossref
Michele Gottardi, Jonathan D. Tyzack, Andreas Bender & Nina Cedergreen. (2018) Can the inhibition of cytochrome P450 in aquatic invertebrates due to azole fungicides be estimated with in silico and in vitro models and extrapolated between species?. Aquatic Toxicology 201, pages 11-20.
Crossref
Arthur I. Cederbaum. (2015) Molecular mechanisms of the microsomal mixed function oxidases and biological and pathological implications. Redox Biology 4, pages 60-73.
Crossref
Tomoki Hoshi, Kazuhiro Yamada, Yuko Yoshizawa & Keimei Oh. (2015) Structure-activity relationship study for fungicidal activity of 1-(4-phenoxymethyl-2-phenyl-[1,3]dioxolan-2-ylmethyl)-1H-1,2,4-triazole derivatives against rice blast. Journal of Plant Protection Research 55:4.
Crossref
Arthur G. Roberts, Sara E. A. Sjögren, Nadezda Fomina, Kathy T. Vu, Adah Almutairi & James R. Halpert. (2011) NMR-Derived Models of Amidopyrine and Its Metabolites in Complexes with Rabbit Cytochrome P450 2B4 Reveal a Structural Mechanism of Sequential N-Dealkylation. Biochemistry 50:12, pages 2123-2134.
Crossref
K. H. M. Nazmul Hussain Nazir, Hirofumi Ichinose & Hiroyuki Wariishi. (2010) Molecular characterization and isolation of cytochrome P450 genes from the filamentous fungus Aspergillus oryzae. Archives of Microbiology 192:5, pages 395-408.
Crossref
Kenneth Bachmann. 2009. Pharmacology. Pharmacology
131
173
.
Bernard Testa & Stefanie D. Krämer. (2007) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 4:3, pages 257-405.
Crossref
Dmitry Korolev, Konstantin V. Balakin, Yuri Nikolsky, Eugene Kirillov, Yan A. Ivanenkov, Nikolay P. Savchuk, Andrey A. Ivashchenko & Tatiana Nikolskaya. (2003) Modeling of Human Cytochrome P450-Mediated Drug Metabolism Using Unsupervised Machine Learning Approach. Journal of Medicinal Chemistry 46:17, pages 3631-3643.
Crossref
Cristina Marques-Soares, Sylvie Dijols, Anne-Christine Macherey, Michael R. Wester, Eric F. Johnson, Patrick M. Dansette & Daniel Mansuy. (2003)
Sulfaphenazole Derivatives as Tools for Comparing Cytochrome P450 2C5 and Human Cytochromes P450 2Cs: Identification of a New High Affinity Substrate Common to Those Enzymes
†
. Biochemistry 42:21, pages 6363-6369.
Crossref
Marcel J. de Groot & Sean Ekins. (2002) Pharmacophore modeling of cytochromes P450. Advanced Drug Delivery Reviews 54:3, pages 367-383.
Crossref
Anton Laak, Nico Vermeulen & Marcel de Groot. 2001. Drug-Drug Interactions. Drug-Drug Interactions
505
548
.
Nguyêt-Thanh Ha-Duong, Sylvie Dijols, Cristina Marques-Soares, Claire Minoletti, Patrick M. Dansette & Daniel Mansuy. (2001) Synthesis of Sulfaphenazole Derivatives and Their Use as Inhibitors and Tools for Comparing the Active Sites of Human Liver Cytochromes P450 of the 2C Subfamily. Journal of Medicinal Chemistry 44:22, pages 3622-3631.
Crossref
David Lewis. 2001. Guide to Cytochromes P450. Guide to Cytochromes P450
164
210
.
Sean Ekins, Jukka Maenpää & Steven Wrighton. 1999. Handbook of Drug Metabolism. Handbook of Drug Metabolism
363
399
.
Rolf-Michael Wittich. 1998. Biodegradation of Dioxins and Furans. Biodegradation of Dioxins and Furans
125
133
.
Ute M. Kent, John R. Bend, Beverly A. Chamberlin, Douglas A. Gage & Paul F. Hollenberg. (1997)
Mechanism-Based Inactivation of Cytochrome P450 2B1 by
N
-Benzyl-1-aminobenzotriazole
. Chemical Research in Toxicology 10:5, pages 600-608.
Crossref
Kuang-pang Li, Ping Chiang & Ruixia Song. 1997. Advances in Environmental Control Technology: Health and Toxicology. Advances in Environmental Control Technology: Health and Toxicology
219
249
.
Lars W. Wormhoudt, Jan H.T.M. Ploemen, Isabelle de Waziers, Jan N.M. Commandeur, Philippe H. Beaune, Peter J. van Bladeren & Nico P.E. Vermeulen. (1996) Inter-individual variability in the oxidation of 1,2-dibromoethane: use of heterologously expressed human cytochrome P450 and human liver microsomes. Chemico-Biological Interactions 101:3, pages 175-192.
Crossref
E.F. Kolesanova, J.G. Kiselar, C. Jung, S.A. Kozin, G. Hui Bon Hoa & A.I. Archakov. (1996) Antigenic mapping of bacterial and animal cytochromes P-450. Biochimie 78:8-9, pages 752-762.
Crossref
G. Feuee & F. A. Iglesia. 1996. Drug-Induced Hepatotoxicity. Drug-Induced Hepatotoxicity
43
73
.
Luc M.H. Koymans, Henri Moereels & Hugo Vanden Bossche. (1995) A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 19 (P450 Aromatase). The Journal of Steroid Biochemistry and Molecular Biology 53:1-6, pages 191-197.
Crossref
John Caldwell, Iain Gardner & Nicola Swales. (2016) An Introduction to Drug Disposition: The Basic Principles of Absorption, Distribution, Metabolism, and Excretion. Toxicologic Pathology 23:2, pages 102-114.
Crossref
M.S. Tute. 1995. Advances in Drug Research Volume 26. Advances in Drug Research Volume 26
45
142
.
B.Kevin Park, Munir Pirmohamed & Neil R. Kitteringham. (1995) The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity. Pharmacology & Therapeutics 68:3, pages 385-424.
Crossref
Paul R. Ortiz de Montellano. 1995. Cytochrome P450. Cytochrome P450
245
303
.
Claes Von Wachenfeldt & Eric F. Johnson. 1995. Cytochrome P450. Cytochrome P450
183
223
.
Daniel Mansuy & Jean-Paul Renaud. 1995. Cytochrome P450. Cytochrome P450
537
574
.
O. Petitjean, P. Nicolas & M. Tod. 1996. Infectious Complications of Cancer. Infectious Complications of Cancer
255
280
.
G Klopman, J Y Li, S Wang, A J Pearson, K Chang, M R Jacobs, S Bajaksouzian & J J Ellner. (1994) In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations.. Antimicrobial Agents and Chemotherapy 38:8, pages 1794-1802.
Crossref
H. Raza & W. Montague. (1994) Metabolism of benzo(a)pyrene, dimethylbenzanthracene and aflatoxin B1 by camel liver microsomes. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 107:3, pages 379-386.
Crossref
Nico P. E. Vermeulen.G. M. Donné-Op Kelder, Jan N. M. Commandeur, F. M. Kaspcrsen, Jos G. M. Bessems, Johan M. Koppele, Patricia A. Dijk, Nico P. E. Vermeulen, Jan P. G. Brakenhoff, Lars W. Wormhoudt, Ed J. Groot, P. Caldirola, G. J. Bijloo, R. Mannhold, E. Coats, H. Timmerman, T. L. Ching, G. R. M. M. Haenen, A. Bast, J. A. M. Christiaans, A. D. Windhorst, P. M. Groenenberg, H. Goot, Ben M. Rooij, Désirée A. Rijksen, Peter J. Boogaard, Nico J. Sittert, W. J. Drijfhout, C. J. Grol, B. H. C. Westerink, J. Ch. Eriks, M. J. E. Fischer, J. J. C. Paulussen, D. A. Horbach, E. P. W. Roelofsen, N. J. Mol, L. H. M. Janssen, J. J. R. Hermans, H. H. W. Thijssen, J. M. Jansen, A. Karlén, U. Hacksell, M. Maliepaard, C. A. M. C. Sitters, W. M. P. B. Menge, A. M. Rhee, E. C. A. Winden, J. F. Nagelkerke, H. J. G. M. Bont, A. P. Ijzerman, W. Soudijn, M. J. A. Veldhuizen, M. G. P. Feenstra, G. J. Boer, W. Vleeming, J. Riezebos, J. G. C. Amsterdam, J. Wemer, D. J. Wildt, A. J. Porsius, T. B. Vree, E. W. J. Ewijk-Beneken Kolmer, M. Biggelaar-Martea, C. P. W. G. M. Wissen-Verwey, M. M. M. Broekman, M. Q. Zhang & D. C. Leysen. (1993) Abstracts of papers. Pharmacy World & Science 15:1, pages 3A-9A.
Crossref